Baxter has “suspended commercial activities” of its intravenous products in China to ease supply issues in the US caused by Hurricane Helene, the company told …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Neuraptive Therapeutics chief operating officer and research and development executive vice-president Evan Tzanis. Credit: Neuraptive Therapeutics, Inc./Business Wire. The US Food and Drug Administration (FDA)
New research has shed light on the complex interplay between cell proteins, and how they impact on neurons in neurodevelopmental disorders and Alzheimer’s disease.
Even as Bayer continues cutting costs across its conglomerate, it’s still making some small R&D deals to add to its pipeline. On Wednesday, the German